This webpage is intended for UK-I healthcare professionals.

▼This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Adverse events and product complaint should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard for the UK or www.hpra.ie for Ireland. Adverse events and product complaint should also be reported to Angelini Pharma on (UK) +44 2034889643, (IRE) +353 1 584 4671 or UKIReporting@angelinipharma.com

ⓘ Click here for Prescribing Information and Adverse Event Reporting

Angelini Pharma Epicast: ONTOZRY^® One Year On

We recently hosted a webinar with some leading HCPs to discuss the launch of ONTOZRY^® and their clinical experience one year on from the launch date.

UK229796P | April 2024

UK23587P | June 2024